You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》康方生物-B(09926.HK)今起招股 入場費16,343.05元
阿思達克 04-14 09:42
康方生物-B(09926.HK)今日(14日)起招股,招股價介乎14.88-16.18元,每手1,000股,入場費16,343.05元,4月17日截止認購申請,料4月24日在主板掛牌。是次聯席保薦人為摩根士丹利及摩根大通。

公司是次發行1.59億股,當中一成公開發售,以招股價中位數15.53計算淨籌約23.37億元,當中75%將用作產品研發及商業化;15%將用於在中國廣州及中山發展生產及研發設施;10%將用於一般公司及營運資金用途。

公司基石投資者包括富達投資、Lake Bleu Prime Healthcare Master Fund、奧博資本、Boyu Capital Opportunities Master Fund、Hudson Bay Master Fund LTD及中國國有企業結構調整基金等,共認投1.63億美元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account